What is one regulatory requirement for non-patient specific compounded preparations?

Non-patient specific compounded preparations must be labeled with the name and strength of the compound to ensure clear identification and safe usage. This requirement is crucial for maintaining patient safety and providing necessary information to healthcare providers who may dispense or utilize these compounded products. The label serves as a vital communication tool, informing users about what the product is and its concentration, which is particularly important in cases where healthcare providers need to make quick clinical decisions.

While other options present considerations for compounded preparations, they do not accurately address the specific labeling requirement. For instance, maintaining a limit on the percentage of non-patient specific compounds within total compounded products is more of an operational guideline than a direct labeling requirement. Similarly, storage conditions and the selection of ingredients may be relevant to compounding practices but do not pertain to the specific regulatory labeling requirement necessary for compliance.